C, L., T, A., & P, D. (2014). The impact on health outcomes and healthcare utilisation of switching to generic medicines consequent to reference pricing: The case of lamotrigine in New Zealand. Applied health economics and health policy, 12(5), 537. https://doi.org/10.1007/s40258-014-0110-0
Chicago Style (17th ed.) CitationC, Lessing, Ashton T, and Davis P. "The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand." Applied Health Economics and Health Policy 12, no. 5 (2014): 537. https://doi.org/10.1007/s40258-014-0110-0.
MLA (9th ed.) CitationC, Lessing, et al. "The Impact on Health Outcomes and Healthcare Utilisation of Switching to Generic Medicines Consequent to Reference Pricing: The Case of Lamotrigine in New Zealand." Applied Health Economics and Health Policy, vol. 12, no. 5, 2014, p. 537, https://doi.org/10.1007/s40258-014-0110-0.